Mahesh Ramniranjan Chamaria

Mahesh Ramniranjan Chamaria

Active Director Director DIN 01997182
DIN 01997182 First appointment Nov 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Nov 2011
Shareholding value •••• Premium profile

About Mahesh Ramniranjan Chamaria

Data last updated:

Mahesh Ramniranjan Chamaria is a Director at Medlife Formulations Private Limited (since 2022), Director at Anuj Printart Private Limited (since 2025) and Director at Green Yellow Bio-Energy Private Limited (since 2022). The companies operate in Pharma, Media and Publishing and Wood. The 2 current companies with reported revenue have a combined latest revenue of ₹78.9 Lakh; the largest is Medlife Formulations Private Limited at ₹48.1 Lakh (FY 2025). Earlier, Mahesh Ramniranjan Chamaria was a Director at Ecoflex Packaging Limited (2024–2025) and Director at Chamaria Agrofarm Private Limited (from 2011).

DIN 01997182
Primary Designation Director
Industry Pharma
First Appointment 16 Nov 2011
Oldest Company Age 31 yrs
Largest company Medlife Formulations Private Limited · ₹48.1 Lakh (FY 2025)
Combined revenue ₹78.9 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medlife Formulations Private Limited U74994MH2013PTC250333
Director23 May 20222013₹48.1 Lakh (FY 2025)Active
Anuj Printart Private Limited U22219MH1995PTC090841
Director20 May 20251995₹30.8 Lakh (FY 2025)Active
Director14 Jan 20222022Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ecoflex Packaging Limited U82920MH2024PLC421700
Director19 Mar 20242024₹24.21 Cr (FY 2025)Active
Chamaria Agrofarm Private Limited U01405MH2011PTC223962
Director16 Nov 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Chamaria Agrofarm Private Limited
Green Yellow Bio-Energy Private Limited
Anuj Printart Private Limited
Medlife Formulations Private Limited
Premium access

Shareholding and investment profile for Mahesh Ramniranjan Chamaria

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahesh Ramniranjan Chamaria

Mahesh Ramniranjan Chamaria currently holds 3 directorships: Medlife Formulations Private Limited (Director, since 23 May 2022, revenue ₹48.1 Lakh (FY 2025)); Anuj Printart Private Limited (Director, since 20 May 2025, revenue ₹30.8 Lakh (FY 2025)); Green Yellow Bio-Energy Private Limited (Director, since 14 Jan 2022).

Mahesh Ramniranjan Chamaria was first appointed on 16 Nov 2011 as Director at Chamaria Agrofarm Private Limited. The most recent appointment on record is 20 May 2025 at Anuj Printart Private Limited.

The 2 current companies of Mahesh Ramniranjan Chamaria that report revenue have a combined latest revenue of ₹78.9 Lakh: Medlife Formulations Private Limited ₹48.1 Lakh (FY 2025); Anuj Printart Private Limited ₹30.8 Lakh (FY 2025).

Mahesh Ramniranjan Chamaria held 2 earlier board appointments: Ecoflex Packaging Limited (Director, 19 Mar 2024 to 10 Sep 2025); Chamaria Agrofarm Private Limited (Director, from 16 Nov 2011).

The current boards of Mahesh Ramniranjan Chamaria's companies include Anuj Mahesh Chamaria (Medlife Formulations Private Limited), Meena Mahesh Chamaria (Medlife Formulations Private Limited), Shubhi Anuj Chamaria (Medlife Formulations Private Limited), Kailash Baburao Nage (Green Yellow Bio-Energy Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available